193 related articles for article (PubMed ID: 9651838)
1. An in vitro bovine pericardial hemocompatibility testing system.
Amrani DL; Lee C; Earles K; DiOrio J; Murphy M; Yang J; Rubalcaba S; LiVecchi A
J Heart Valve Dis; 1998 May; 7(3):268-72. PubMed ID: 9651838
[TBL] [Abstract][Full Text] [Related]
2. Glutaraldehyde detoxification in addition to enhanced amine cross-linking dramatically reduces bioprosthetic tissue calcification in the rat model.
Weissenstein C; Human P; Bezuidenhout D; Zilla P
J Heart Valve Dis; 2000 Mar; 9(2):230-40. PubMed ID: 10772041
[TBL] [Abstract][Full Text] [Related]
3. [Hemocompatibility of bovine pericardium with additional sodium bisulfite treatment].
Han MS; Zhou JY; Hu SS; Wang S; Jiang H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):638-41. PubMed ID: 18051720
[TBL] [Abstract][Full Text] [Related]
4. Nanocoating with titanium reduces iC3b- and granulocyte-activating immune response against glutaraldehyde-fixed bovine pericardium: a new technique to improve biologic heart valve prosthesis durability?
Guldner NW; Bastian F; Weigel G; Zimmermann H; Maleika M; Scharfschwerdt M; Rohde D; Sievers HH
J Thorac Cardiovasc Surg; 2012 May; 143(5):1152-9. PubMed ID: 22153860
[TBL] [Abstract][Full Text] [Related]
5. Detoxified glutaraldehyde cross-linked pericardium: tissue preservation and mineralization mitigation in a subcutaneous rat model.
Valente M; Pettenazzo E; Thiene G; Molin GM; Martignago F; De Giorgi G; Gatti AM; Giaretta A; Pasquino E; Talenti E; Rinaldi S
J Heart Valve Dis; 1998 May; 7(3):283-91. PubMed ID: 9651841
[TBL] [Abstract][Full Text] [Related]
6. Detoxification and endothelialization of glutaraldehyde-fixed bovine pericardium with titanium coating: a new technology for cardiovascular tissue engineering.
Guldner NW; Jasmund I; Zimmermann H; Heinlein M; Girndt B; Meier V; Flüss F; Rohde D; Gebert A; Sievers HH
Circulation; 2009 Mar; 119(12):1653-60. PubMed ID: 19289635
[TBL] [Abstract][Full Text] [Related]
7. Ionescu-Shiley bovine pericardial bioprostheses. Histologic and ultrastructural studies.
Hilbert SL; Ferrans VJ; McAllister HA; Cooley DA
Am J Pathol; 1992 May; 140(5):1195-204. PubMed ID: 1580331
[TBL] [Abstract][Full Text] [Related]
8. In vitro haemocompatibility of a novel bioprosthetic total artificial heart.
Jansen P; van Oeveren W; Capel A; Carpentier A
Eur J Cardiothorac Surg; 2012 Jun; 41(6):e166-72. PubMed ID: 22491668
[TBL] [Abstract][Full Text] [Related]
9. A novel anti-calcification strategy of bovine pericardium using sodium bisulfite modification.
Zhou J; Jiang H; Wang D; Hu S
J Heart Valve Dis; 2009 Mar; 18(2):180-5; discussion 186. PubMed ID: 19455893
[TBL] [Abstract][Full Text] [Related]
10. Microscopic study of normal parietal pericardium and unimplanted Puig-Zerbini pericardial valvular heterografts.
Allen DJ; DiDio LJ; Zacharias A; Fentie I; McGrath AJ; Puig LB; Pomerantzeff PN; Zerbini EJ
J Thorac Cardiovasc Surg; 1984 Jun; 87(6):845-55. PubMed ID: 6727408
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of calcification with citric acid in pericardial bioprosthetic heart valve material: a preliminary report.
Sucu N; Tamer L; Aytacoglu B; Polat A; Dondas HA; Gul A; Dikmengil M; Atik U
J Heart Valve Dis; 2004 Jul; 13(4):697-700. PubMed ID: 15311880
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of in vivo models for studying calcification behavior of commercially available bovine pericardium.
Quintero LJ; Lohre JM; Hernandez N; Meyer SC; McCarthy TJ; Lin DS; Shen SH
J Heart Valve Dis; 1998 May; 7(3):262-7. PubMed ID: 9651837
[TBL] [Abstract][Full Text] [Related]
13. In vitro calcification of pericardial bioprostheses.
Glasmacher B; Reul H; Schneppershoff S; Schreck S; Rau G
J Heart Valve Dis; 1998 Jul; 7(4):415-8. PubMed ID: 9697064
[TBL] [Abstract][Full Text] [Related]
14. The pericardial bioprosthesis: altered tissue shear properties following glutaraldehyde fixation.
Boughner DR; Haldenby M; Hui AJ; Dunmore-Buyze J; Talman EA; Wan WK
J Heart Valve Dis; 2000 Nov; 9(6):752-60. PubMed ID: 11128780
[TBL] [Abstract][Full Text] [Related]
15. Biomechanical characterization of decellularized and cross-linked bovine pericardium.
Oswal D; Korossis S; Mirsadraee S; Wilcox H; Watterson K; Fisher J; Ingham E
J Heart Valve Dis; 2007 Mar; 16(2):165-74. PubMed ID: 17484467
[TBL] [Abstract][Full Text] [Related]
16. Determinants of calcium uptake of bovine pericardium for heart valve replacement: results of in vitro studies.
Dahm M; Dohmen G; Prüfer D; Krummenauer F; Hafner G; Oelert H
J Heart Valve Dis; 1998 Mar; 7(2):170-3. PubMed ID: 9587857
[TBL] [Abstract][Full Text] [Related]
17. Anisotropic elasticity and strength of glutaraldehyde fixed bovine pericardium for use in pericardial bioprosthetic valves.
Zioupos P; Barbenel JC; Fisher J
J Biomed Mater Res; 1994 Jan; 28(1):49-57. PubMed ID: 8126028
[TBL] [Abstract][Full Text] [Related]
18. Diamine-extended glutaraldehyde- and carbodiimide crosslinks act synergistically in mitigating bioprosthetic aortic wall calcification.
Zilla P; Bezuidenhout D; Torrianni M; Hendriks M; Human P
J Heart Valve Dis; 2005 Jul; 14(4):538-45. PubMed ID: 16116882
[TBL] [Abstract][Full Text] [Related]
19. Detoxification process for glutaraldehyde-treated bovine pericardium: biological, chemical and mechanical characterization.
Stacchino C; Bona G; Bonetti F; Rinaldi S; Della Ciana L; Grignani A
J Heart Valve Dis; 1998 Mar; 7(2):190-4. PubMed ID: 9587860
[TBL] [Abstract][Full Text] [Related]
20. The effects of collagen fiber orientation on the flexural properties of pericardial heterograft biomaterials.
Mirnajafi A; Raymer J; Scott MJ; Sacks MS
Biomaterials; 2005 Mar; 26(7):795-804. PubMed ID: 15350785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
